12-Month Outcomes

Want create site? Find Free WordPress Themes and plugins.

LunaLiving Recovery is a CARF accredited, State of Ohio licensed mental health facility for the treatment of substance use disorders. The 30-day partial hospitalization program is a uniquely constructed ecosystem designed to retrieve and heal the hijacked brain.


The LunaLiving Ecosystem includes:

  • 7-10 day patent-pending NAD+ detox
  • Neurofeedback
  • Sugar-free/gluten-free nutrition
  • Experiential group, family and individual therapies
  • Energy medicine
  • Alumni activities

Outcomes based on abstinence for patients admitted from February 2016 through March 2017 were 10x higher than the national average. Utilizing our proprietary protocol of NAD+ to provide real and immediate relief from the biochemical underpinnings of the disease (cravings and clarity), allows for meaningful therapeutic services to begin sooner. Patient stability and resilience,significantly improved outcomes, and an overall improved patient experience were observed and measured utilizing standardized scales such as the DASS21, BASIS-24, CIWA, and COWS

Thumb
Thumb
  • Group 1 (n=33) received 10-14 continuous days standard NAD+ therapy in conjunction with 1 hour of daily therapy. Patients returned periodically for ongoing NAD boosters.
  • Group 2 (n=21) received 7-10 days of proprietary NAD+ therapy, in conjunction with experiential group therapy, family therapy, meditation, neurofeedback, journaling and educational programming.
    • 5 continuous days, weekend break, 2-5 additional days.

LunaLiving COWS Average Scores Relative
to Highest Possible COWS Score

Thumb

The Clinical Opiate Withdrawal Scale has a range from 0-48. Mild symptoms range from 5-12. LunaLiving assesses patients every two-four hours, beginning on day 1 of detox through the final day of detox. All averages are below 5, indicating the need for minimal symptom management.

LunaLiving CIWA Average Scores Relative
to Highest Possible CIWA Score

Thumb

The Clinical Institute Withdrawal Assessment for Alcohol has a range from 0-67. Scores under 12 require no medical intervention. LunaLiving assesses patients every two-four hours, beginning on day 1 of detox through the final day of detox. All averages are below 5, indicating the need for minimal symptom management.

Group 1 ( 2/16 – 10/16 )

  • 37 total clients
  • 89% program completion rate (33 clients)
  • 30% continuous sobriety
  • 21% ongoing sobriety with interruptions
    • 1-4 interruptions
    • Patients returned for ongoing NAD therapy
  • 48% full relapse
Group One produced an overall success rate of 51%.

LunaLiving Group 1
(N=33 out of possible 37)

Thumb

Group 2 ( 11/16 – 4/17 )

  • 24 clients
  • 88% program completion rate (21 out of 24 clients)
  • 57% continuous sobriety
  • 29% ongoing sobriety with interruptions
    • 1-3 interruption
    • Patients returned for ongoing NAD therapy
  • 14% total relapse
Group Two produced an overall success rate of 86%.

LunaLiving Group 2
(N=21 out of possible 24)

Thumb
By Comparison: Traditional Treatment Results
Current Standard of Care for Opiate Dependence – Inpatient Detoxification

traditional treatment outcomes

Thumb

A specialist inpatient Drug Dependency Unit in Dublin, Cuan Dara, published data in 2010 on follow–up of 109 patients suffering from opiate addiction. The inpatient abstinence program lasted 6 weeks. Opiate detoxification using methadone occurred during the first 10 days, followed by lofexidine for 7 days. Psychosocial interventions included group therapy, individual therapy and in addition family therapy was provided where needed. Following discharge, 103 (94%) of the 109 patients interviewed reported a lapse (defined as any misuse of an opiate following discharge from treatment), and 99 (91%) reported a relapse (defined as a return to a pattern of daily opiate use). Within one week of discharge, 72 (66%) had lapsed and 64 (59%) had relapsed. Within one month these proportions had risen to 80% and 71% respectively. Relapse occurred within a week of the initial lapse in 74% cases. The gap between lapse and relapse was greater than one month in only 15% of cases. 80% of those who relapsed did so within the first month after discharge.

iSmyth BP et al. Lapse and relapse following inpatient treatment of opiate dependence. 2010, 103(6): 176-9 Ir Med J.

Did you find apk for android? You can find new Free Android Games and apps.